T1	Concept 37 42	males
T2	Concept 60 92	Middle East respiratory syndrome
T3	Concept 100 103;94 98	CoV MERS
T4	Concept 108 116	SARS-CoV
*	same-as T2 T3
T5	Action 48 56	infected
R1	subject Arg1:T5 Arg2:T2	
R2	subject Arg1:T5 Arg2:T4	
R3	target Arg1:T5 Arg2:T1	
A1	Emphasized T1
T6	Concept 148 156	SARS-CoV
T7	Action 138 147	inhibited
T8	Action 185 192	blocked
T9	Action 196 207	interaction
T10	Concept 220 228	SARS-CoV
T11	Concept 229 242	spike protein
T12	Concept 247 251	ACE2
R4	has-property Arg1:T10 Arg2:T11	
R5	subject Arg1:T9 Arg2:T10	
R6	subject Arg1:T9 Arg2:T12	
R7	target Arg1:T8 Arg2:T9	
T13	Concept 168 178	3a protein
R8	has-property Arg1:T6 Arg2:T13	
R9	target Arg1:T7 Arg2:T13	
T14	Concept 131 137	emdoin
R10	subject Arg1:T7 Arg2:T14	
R11	subject Arg1:T8 Arg2:T14	
T15	Concept 256 272	transmissibility
T16	Concept 302 310	SARS-CoV
T17	Concept 314 318	2003
T18	Action 372 381	spreading
T19	Concept 385 393	Covid-19
R12	subject Arg1:T18 Arg2:T19	
T20	Concept 346 356	consistent
T21	Concept 277 283	higher
R13	has-property Arg1:T15 Arg2:T21	
R14	has-property Arg1:T15 Arg2:T20	
R15	in-context Arg1:T20 Arg2:T18	
R16	in-context Arg1:T21 Arg2:T16	
R17	in-place Arg1:T16 Arg2:T17	
T22	Concept 414 422	SARS-CoV
T23	Concept 423 438	S-RBD structure
R18	has-property Arg1:T22 Arg2:T23	
T24	Action 476 509	high-resolution homology modeling
T25	Action 531 538	predict
T26	Concept 543 551	3D model
R19	target Arg1:T25 Arg2:T26	
R20	subject Arg1:T25 Arg2:T24	
R21	in-context Arg1:T25 Arg2:T23	
T27	Concept 567 575	SARS-CoV
T28	Concept 576 592	antigen staining
T29	Concept 633 653	antigen distribution
T30	Concept 673 677	Muc4
T31	Concept 684 686	WT
T32	Concept 702 708	airway
T33	Concept 716 736	parenchymal staining
R24	has-property Arg1:T27 Arg2:T28	
T34	Concept 618 629	differences
R22	in-context Arg1:T29 Arg2:T30	
R23	in-context Arg1:T29 Arg2:T31	
R25	has-property Arg1:T29 Arg2:T34	
A2	Negated T34
R26	entails Arg1:T28 Arg2:T34	
R27	in-place Arg1:T29 Arg2:T32	
R28	in-place Arg1:T29 Arg2:T33	
